Submassive Pulmonary Embolism.
Rali PM, Criner GJ.
Am J Respir Crit Care Med. 2018 Sep 1;198(5):588-598. doi: 10.1164/rccm.201711-2302CI.
Diagnosis and Management of Pulmonary Embolism.
Trott T, Bowman J.
Emerg Med Clin North Am. 2022 Aug;40(3):565-581. doi: 10.1016/j.emc.2022.05.008. Epub 2022 Jul 8.
A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.
Piazza G, Hohlfelder B, Jaff MR, Ouriel K, Engelhardt TC, Sterling KM, Jones NJ, Gurley JC, Bhatheja R, Kennedy RJ, Goswami N, Natarajan K, Rundback J, Sadiq IR, Liu SK, Bhalla N, Raja ML, Weinstock BS, Cynamon J, Elmasri FF, Garcia MJ, Kumar M, Ayerdi J, Soukas P, Kuo W, Liu PY, Goldhaber SZ; SEATTLE II Investigators.
JACC Cardiovasc Interv. 2015 Aug 24;8(10):1382-1392. doi: 10.1016/j.jcin.2015.04.020.
Acute pulmonary embolism.
Howard L.
Clin Med (Lond). 2019 May;19(3):243-247. doi: 10.7861/clinmedicine.19-3-247.
Intermediate-Risk Pulmonary Embolism: A Review of Contemporary Diagnosis, Risk Stratification and Management.
Machanahalli Balakrishna A, Reddi V, Belford PM, Alvarez M, Jaber WA, Zhao DX, Vallabhajosyula S.
Medicina (Kaunas). 2022 Aug 30;58(9):1186. doi: 10.3390/medicina58091186.
Submassive pulmonary embolism.
Busse LW, Vourlekis JS.
Crit Care Clin. 2014 Jul;30(3):447-73. doi: 10.1016/j.ccc.2014.03.006.
Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial.
Kline JA, Nordenholz KE, Courtney DM, Kabrhel C, Jones AE, Rondina MT, Diercks DB, Klinger JR, Hernandez J.
J Thromb Haemost. 2014 Apr;12(4):459-68. doi: 10.1111/jth.12521.
Submassive and Massive Pulmonary Embolism: An Updated Review of Definition, Diagnosis, and Treatment Strategies.
Choi MH, Elfatatry Y, Darki A, Brailovsky Y.
Med Clin North Am. 2025 Jul;109(4):827-856. doi: 10.1016/j.mcna.2025.02.012. Epub 2025 Apr 28.
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.
Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, Jenkins JS, Kline JA, Michaels AD, Thistlethwaite P, Vedantham S, White RJ, Zierler BK; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology.
Circulation. 2011 Apr 26;123(16):1788-830. doi: 10.1161/CIR.0b013e318214914f. Epub 2011 Mar 21.
Advanced Management of Intermediate- and High-Risk Pulmonary Embolism: JACC Focus Seminar.
Piazza G.
J Am Coll Cardiol. 2020 Nov 3;76(18):2117-2127. doi: 10.1016/j.jacc.2020.05.028.
